Osaic Holdings’s Enveric Biosciences ENVB Stock Holding History

Osaic Holdings’s Portfolio ENVB Stock Details ENVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Buy	+1	New	+$2	﹤0.01%	7982
2024 Q4	–	Sell	-3	Closed	-$271	–	7473
2024 Q3	$271	Hold	3	–	–	﹤0.01%	7124
2024 Q2	$385	Buy	3 +2	+200%	+$301	﹤0.01%	7047
2024 Q1	$150	Hold	1	–	–	﹤0.01%	7001
2023 Q4	$195	Sell	1 -1	-50%	-$307	﹤0.01%	7045
2023 Q3	$714	Buy	+2	New	+$901	﹤0.01%	6916
2023 Q2	–	Sell	-1	Closed	-$249	–	7487
2023 Q1	$249	Hold	1	–	–	﹤0.01%	7238
2022 Q4	$0	Buy	+1	New	+$553	﹤0.01%	7248
2022 Q2	–	Hold	0	–	-$1K	–	7409
2022 Q1	–	Hold	0	–	–	–	7026
2021 Q4	–	Hold	0	–	–	–	6740
2021 Q3	–	Hold	0	–	–	–	6270
2021 Q2	–	Hold	0	–	–	–	6243
2021 Q1	–	Hold	0	–	–	–	6357
2020 Q4	–	Hold	0	–	–	–	5836
2020 Q3	–	Hold	0	–	–	–	5496

Other funds holding ENVB

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's ENVB Position: Q2 2026 in Review

Osaic Holdings opened a new position in Enveric Biosciences (ENVB) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #7982 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in ENVB as recently as Q3 2024.

Osaic Holdings first reported a position in ENVB in Q4 2022 and has held it in 8 quarters since. The position peaked at $714 in Q3 2023. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

Osaic Holdings held 1 share of Enveric Biosciences worth $1 as of Q2 2026.
Enveric Biosciences was a new Osaic Holdings position in Q2 2026.
Enveric Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7982 holding.
Osaic Holdings first reported a position in Enveric Biosciences in Q4 2022 and has held it in 8 quarters since.
Osaic Holdings's Enveric Biosciences position peaked at $714 in Q3 2023.
24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.